Grade: Pharmaceutical Grade

Factory Location: Quanzhou

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Sample Provided: no

Payment Terms: L/C

Idabicin hydrochloride is a primary anti-mitotic and cytotoxic agent. It is used for the first-line treatment of acute non-lymphocytic leukemia (ANLL) in adults and for the induction of remission in relapsed and refractory patients. It is used as a second-line treatment for acute lymphocytic leukemia (ALL) in adults and children.